| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3275725 | Médecine des Maladies Métaboliques | 2011 | 4 Pages |
Abstract
Two cases reports permitted to prove the benefit of combined pancreatic islet transplantation performed by islet intraportal injection in patients with cystic fibrosis by restoring both lung function and metabolic control. A multicenter, pilot study should confirm these results. By restoring an endogen insulin production and an optimal glucose control, the expected result is that islet transplantation reduces the morbidity of lung transplantation and improves the quality of life in patients with CFRD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
L. Kessler, M. Greget, G. Massard, N. Santelmo, F. Moreau, T. Berney, R. Kessler,